ExodusPoint Capital Management’s Ventyx Biosciences VTYX Stock Holding History

ExodusPoint Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,009	Closed	-$452K	–	2147
2025 Q4	$452K	Buy	+50,009	New	+$374K	﹤0.01%	1201
2024 Q4	–	Sell	-76,007	Closed	-$166K	–	2113
2024 Q3	$166K	Buy	+76,007	New	+$175K	﹤0.01%	1473
2024 Q2	–	Sell	-44,911	Closed	-$247K	–	2022
2024 Q1	$247K	Buy	+44,911	New	+$205K	﹤0.01%	1306
2023 Q3	–	Sell	-6,994	Closed	-$229K	–	2186
2023 Q2	$229K	Sell	6,994 -179,055	-96%	-$6.17M	﹤0.01%	1642
2023 Q1	$6.23M	Buy	+186,049	New	+$7.23M	0.05%	437
2022 Q4	–	Sell	-11,867	Closed	-$414K	–	2179
2022 Q3	$414K	Buy	+11,867	New	+$263K	0.01%	1436

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ExodusPoint Capital Management's VTYX Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 50,009 shares — an estimated $452K sold.

ExodusPoint Capital Management first reported a position in VTYX in Q3 2022 and held it in 6 quarters. The position peaked at $6.23M in Q1 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

ExodusPoint Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 50,009 Ventyx Biosciences shares in Q1 2026, an estimated $452K.
ExodusPoint Capital Management first reported a position in Ventyx Biosciences in Q3 2022 and held it in 6 quarters.
ExodusPoint Capital Management's Ventyx Biosciences position peaked at $6.23M in Q1 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.